Lectures final Flashcards
What is the ECM and whats it made of
- The extracellular matrix (ECM) is a dynamic structure that is constantly remodelled to control tissue homeostasis
- The ECM in mammals is composed of around 300 proteins, known as the core matrisome
what are ECM characteristics and roles
Different tissues have unique and specialized extracellular matrix (ECM) components and organization, which enables each ECM to carry out tissue-specific roles, including structural support, the transmission of forces and macromolecular filtration.
The molecules that are associated with the ECM of each tissue, including collagens, proteoglycans, laminins and fibronectin, and the manner in which they are assembled determine the structure and the organization of the resultant ECM.
What is ECM made of
The fibrous (collagens and elastin) and glycoprotein (fibronectin, proteoglycans and laminins) macromolecules that constitute the ECM have evolved structures and chemical properties that are particularly suited to their specific biological functions in their respective tissues
The architecture of the ECM is highly organized, which partly arises from the innate properties of its constituent molecules and their interactions and partly from the activities of the resident cells
Each class of ECM molecule is designed to interact with another class to produce unique physical and signalling properties that support tissue structure, growth and function.
Uses of ECM
Small intestinal submucosa (SIS) is a native collagen-based extracellular matrix (ECM) of submucosal layer of intestinal wall
Decellularized ECM as a vascular graft
Stem cell growth support
What are ECM vascular graphs used for, limitations, requirements
Vascular prostheses (grafts) are widely used for hemodialysis blood access, trauma repair, aneurism repair, and cardiovascular reconstruction.
Smaller-diameter (≤4 mm) grafts that would be valuable for many reconstructions have not been achieved to date, although hundreds of papers on small-diameter vascular grafts have been published.
General requirements
- not thrombose (clog)
not trigger hyperplasia (excessive growth of cells around it)
- maintain mechanical integrity
- meet surgeon handling requirements (e.g., suturability).
current situation on synthetic graphs (standard, what uses, issues)
- Vascular grafts used in surgery today are composed primarily of expanded Teflon (ePTFE) or Dacron fabric (polyethylene terephthalate (PET)).
- ≤4 mm grafts could be used for limb blood vessel replacement, possibly saving many of the roughly 1 million limbs amputated each year worldwide.
Arterio-venous grafts used for dialysis access also have a high failure rate at 1 to 2 years, leading to expensive reoperations. (fail due to hyperplasia -> thrombosis)
Nylon grafts fail rapidly due to degradation—the amide backbone chemistry of nylon is identical to the amide backbone of proteins and the body has highly efficient enzymatic mechanisms for breaking down unwanted polyamides.
Burst strength of the grafts can be problematic
Autologous vessels still outperform decellularized vessel grafts and are the optimal standard of care
Duration of implantation of vascular graphs
around 1 month animal studies
(Sometimes 3 or 6 months)
in humans: if Degradation and aneurism -> in the 5- to 10-year implant period.
scCO2 grafts vs detergent decell grafts
vascular grafts produced by detergent methods may result in defective vessel wall structures, detergent residues, and the development of aneurysms after grafting.
ScCO2:
- higher biocompatibility,
- enhanced chemotactic migration of endothelial progenitor cells (chemically attracts blood stem cells),
- lower risk of vasculopathy,
- lower inflammatory and splenic immune responses
- better physiological-like tension responses after xenotransplantation (XTP)
Whole organ engineering
- decellularization of the organ, (creates an acellular scaffold consisting of structural proteins such as collagen and laminins, as well as proteoglycans and polysaccharides)
maintains the organ’s composition, architecture, and mechanical properties. - scaffold seeded with progenitor cells and cultured in a bioreactor to mimic the natural heart functions.
- A bioreactor supports and protects the engineered construct, providing nutrients and a sterile environment.
How to test an engineered the heart as a bioengineer
Tissue function test
Sterility
mechanical properties
cell distribution/viability
electrophysiology
methods of decell
(a) Chemical – detergents: Sodium Dodecyl Sulfate (SDS), Triton X100, CHAPS, acids/bases, hypotonic/hypertonic solutions, alcohols, solvents.
(b)Biological – enzymes and nucleases: Deoxyribonucleases (DNases), Endonucleases, Trypsin, chelating agents.
(c)Physical – temperature, pressure, electroporation, and impact/force: mechanical agitation, slicing, mincing.
scCO2 advantages
what does it solvate
- sterilization
- inert, non-toxic
can extract undamaged ECM components maintaining the original structures of polymers and proteins from native tissues
low reactivity to polar components (protein, polysaccharide chain) hinder biomolecule denaturation during the tissue extraction process
scCO2 -> liquid-like solute solubility and gas-like diffusion ability, which increases the CO2 tissue penetration ability and solubility of nonpolar molecules in the tissues
->increase DNA elimination and the tissue extraction efficiency compared to chemical solution-based decellularization methods
Applications of decellularized tissues : 3D scaffold fabrication strategies
A) Process of decellularized tissue derived hydrogel fabrication.
B) flow tunable decelluarization method for whole human limb.
C) Decelluarized liver tissue cube fabrication for angiogenesis.
D) 3D printer technologies using bio ink formulation.
E) endodermal (gastric) organoid using decellularized ECM, epithelial (zonula occludens-1, epithelial cadherin and actin) and gastric (ezrin and mucin-5AC) markers
How can we engineer macroscopic designs for hydrogel solute transport
- The spacing between polymer molecules in the network (that is, the mesh size) is tuneable from around 5 to around 100 nm
- At the molecular (or atomistic) scale, drugs can interact with the polymer chains via a range of mechanisms like covalent linkage to a polymer chain
Requirements for hydrogel drug delivery systems
maintain the drug bioactivity, and through packaging, transport and storage, both the drug and hydrogel must be chemically and physically stable.
hydrogel should degrade on its own or be refillable,